Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine

Author： Nolan T. McIntyre P. Roberton D. Descamps D.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.21, Iss.3, 2002-12, pp. : 281-289

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reactogenicity and immunogenicity of a new combined Measles-Mumps-Rubella vaccine: results of a multicentre trial

By Crovari P. Gabutti G. Giammanco G. Dentico P. Moiraghi A.R. Ponzio F. Soncini R.

Vaccine, Vol. 18, Iss. 25, 2000-06 ,pp. : 2796-2803

Elsevier

Access to resources Recommend Favorite

Comparison of immunogenicity and reactogenicity of a measles, mumps and rubella (MMR) vaccine in German children vaccinated at 9-11, 12-14 or 15-17 months of age *

By Klinge

Vaccine, Vol. 18, Iss. 27, 2000-07 ,pp. : 3134-3140

Elsevier

Access to resources Recommend Favorite

Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance

By Pebody R.G. Gay N.J. Hesketh L.M. Vyse A. Morgan-Capner P. Brown D.W. Litton P. Miller E.

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1134-1140

Elsevier

Access to resources Recommend Favorite

Immunogenicity and efficacy of one dose measles-mumps-rubella (MMR) vaccine at twelve months of age as compared to monovalent measles vaccination at nine months followed by MMR revaccination at fifteen months of age

By Ceyhan M. Kanra G. Erdem G. Kanra B.

Vaccine, Vol. 19, Iss. 31, 2001-08 ,pp. : 4473-4478

Elsevier

Access to resources Recommend Favorite

Vaccine-induced measles virus antibodies after two doses of combined measles, mumps and rubella vaccine: a 12-year follow-up in two cohorts

By Davidkin I. Valle M.

Vaccine, Vol. 16, Iss. 20, 1998-12 ,pp. : 2052-2057

Elsevier

Access to resources Recommend Favorite